By activating both GIP and GLP-1 receptors, Zepbound enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways
In animal models of diet-induced obesity, co-administration of cagrilintide and semaglutide produced additive suppression of food intake, greater fat mass loss, and improved metabolic markers beyond what either compound achieved alone
Healthcare providers look at several factors to decide if semaglutide or orlistat is the right choice
You already have a prescription from anywhere and want daily tracking, not another program, at the center of your journey
I felt I had more control over my eatingI felt I was better able to make choices. (P7, male, diabetes)
However, even these individuals typically see improvement as treatment continues